全文获取类型
收费全文 | 10308篇 |
免费 | 869篇 |
国内免费 | 448篇 |
专业分类
耳鼻咽喉 | 119篇 |
儿科学 | 208篇 |
妇产科学 | 63篇 |
基础医学 | 869篇 |
口腔科学 | 218篇 |
临床医学 | 1172篇 |
内科学 | 908篇 |
皮肤病学 | 111篇 |
神经病学 | 215篇 |
特种医学 | 426篇 |
外科学 | 1078篇 |
综合类 | 2406篇 |
现状与发展 | 1篇 |
预防医学 | 1158篇 |
眼科学 | 119篇 |
药学 | 1124篇 |
12篇 | |
中国医学 | 935篇 |
肿瘤学 | 483篇 |
出版年
2024年 | 61篇 |
2023年 | 137篇 |
2022年 | 312篇 |
2021年 | 412篇 |
2020年 | 367篇 |
2019年 | 176篇 |
2018年 | 216篇 |
2017年 | 267篇 |
2016年 | 225篇 |
2015年 | 386篇 |
2014年 | 450篇 |
2013年 | 557篇 |
2012年 | 896篇 |
2011年 | 841篇 |
2010年 | 770篇 |
2009年 | 729篇 |
2008年 | 677篇 |
2007年 | 674篇 |
2006年 | 528篇 |
2005年 | 459篇 |
2004年 | 353篇 |
2003年 | 284篇 |
2002年 | 243篇 |
2001年 | 214篇 |
2000年 | 188篇 |
1999年 | 91篇 |
1998年 | 38篇 |
1997年 | 27篇 |
1996年 | 42篇 |
1995年 | 32篇 |
1994年 | 23篇 |
1993年 | 24篇 |
1992年 | 38篇 |
1991年 | 85篇 |
1990年 | 69篇 |
1989年 | 72篇 |
1988年 | 61篇 |
1987年 | 61篇 |
1986年 | 51篇 |
1985年 | 51篇 |
1984年 | 38篇 |
1983年 | 27篇 |
1979年 | 30篇 |
1978年 | 26篇 |
1975年 | 25篇 |
1974年 | 33篇 |
1973年 | 26篇 |
1972年 | 26篇 |
1971年 | 23篇 |
1969年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
隐动脉筋膜蒂的交腿皮瓣修复小腿严重软组织缺损 总被引:7,自引:2,他引:5
目的探讨一种小腿严重软组织缺损的修复方法。方法以健侧隐动脉为蒂的顺行或逆行交腿皮瓣修复患侧小腿软组织缺损。结果本组8例均有效地覆盖受区创面,随访三个月,皮瓣全部成活。结论该皮瓣不牺牲小腿的重要血管,质地与受区相似,方法简单易行,血运可靠,血管蒂长,是修复小腿严重软组织缺损的较好方法。 相似文献
52.
鼠骨关节炎动物模型建立的现状 总被引:12,自引:2,他引:10
骨关节炎(osteoarthritis,OA)是临床上常见的疾病。探索骨关节炎动物模型的建立方法,是研究其病因和治疗方法的重要课题之一。鼠是一种理想的动物,所用的方法有关节内手术、关节内注射、关节外手术等,各种方法都有自己的长处和不足。本文就鼠骨关节炎动物模型的建立方法、模型特点及其应用等方面进行综述。 相似文献
53.
54.
目的对比短程化疗含链霉素(SM)、乙胺丁醇(EMB)两组方案在抗结核治疗中的效果。方法选初治菌阳肺结核100例,予含SM方案(2HRZS/7HR)化疗50例,含EMB方案(2HRZE/7HR)化疗50例。每月检查痰结核菌一次(涂片三次,培养一次)。停药后继续追踪两年。结果痰菌2个月内转阴者,SM组29例,占63%;EMB组18例,占38%,p<0.05,有显著性差异。需延长强化期者:SM组16例,占35%;EMB组26例,占55%,p<0.05,有显著性差异。复发病例,SM组2例,占4%;EMB组3例,占6%,p>0.05,无显著性差异。结论使用含SM方案化疗的病例其痰菌转阴时间比含EMB方案短。 相似文献
55.
56.
D A Kuznetsov 《The International journal of neuroscience》1989,49(1-2):43-59
As a result of the complex comparative neurochemical study of the translation machinery functioning in the brain cells of three conventionally "phylogenetically related" species of wild timber voles (Clethrionomys glareolus, Clethrionomys frater and Clethrionomys gapperi), it has been found that the cytoplasm of brain cells of the latter contain an oligonucleotide (oligoribonucleotide) factor(s) with mol. weight below 1.0 KD which is able completely and highly selectively to inhibit the translation directed by mRNA which are species-specific templates and which were isolated from analogical tissue (brain) of "closely related" organisms. This phenomenon was found for the first time using special Cell-Free Translation Systems (CFTS) of very different variants of their composition consisting of the following main components: Post-Mitochondrial Supernatant (PMS), total cytoplasmic poly(A)+ mRNA or a species-specific poly(A)+ mRNA isolated form the PMS by affinity chromatography on the columns with the anti-mRNA1-FAB-(CNBr)-Sepharose, or purified 9S or 11S globin or histone specific mRNAs, respectively, and, finally a few samples of the CFTS used contain the additions of high or low molecular weight cytosolic compounds isolated from S150 fraction by ultrafiltration on Diaflo UM2 membrane with an exclusion limit of 1.0 KD. All CFTs components listed were isolated separately from the brain tissue of each organism studied. A new complex way for construction and using of the CFTS leads to an adequately documented conclusion which suggested the existence of special, so far uncharacterized in detail, cytoplasmic oligoribonucleotide factor(s) for efficient blocking for the cytoplasmic expression of "evolutionally renovated part" of genome; i.e., these factors seem to be sufficiently powerful suppressors of the translation of every mRNA template if the latter is not usual for the cell type containing the cytoplasmic suppressors mentioned in the case of a "so-called" newly found (perhaps, due to spontaneous but nonlethal mutagenesis) genes expression at the level of mRNA functioning in the cytoplasm. All findings and ideas of the paper are under discussion. 相似文献
57.
Neurospecific translation control and the problem of potent danger of drugs and chemicals: a caution
D A Kuznetsov 《The International journal of neuroscience》1989,49(1-2):1-42
At present, chemicals are an integral part of the surrounding biosphere. A great number of new xenobiotics for industrial, pharmaceutical, agricultural, or mode-of-life daily use (perfumes, cosmetics, food additives, etc.) may play a role of a danger health hazards. These chemicals may be environmental pollutants and due to this circumstance they promote different ecological disorders including the several epidemic-like processes such as, for instance, Minamata disease (chronic alimentary poisoning with methyl mercury), etc. Also, these chemicals may be industrial hazards promoting the origin and development of various occupational diseases. Finally, the numerous side effects of multiple new drugs may serve as causes of a number of different health disorders. Briefly, we must agree that modern man exists in the world with such inalienable elements as the steadfast increase of chemical soiling of Earths biosphere. Naturally, human health protection in our "chemically soiled" world is very difficult by urgent task. As for the solving of this task, it may be reached only in the case of successful fundamental studies of mechanisms of toxic action of different classes of chemicals performed at different biological levels (systemic, organ/tissue, cellular and molecular levels of research). A separate and special population of modern health-hazardous chemicals is a group of agents which selectively suppress protein synthesis in mammalian cells and tissues due to the direct effect on the translation machinery elements or on the messenger RNA processing steps. The agents of this group ("translation blockers" or, the same but more broadly, "protein synthesis inhibitors" (PSI) usually are quite dangerous for human health since these substances inhibit the central molecular process of life, i.e., the synthesis of protein molecules. The small but important subclass of the PSI is represented by the agents with marked neurotropic properties, i.e., by the agents which are able to promote the effective inhibition of protein synthesis in the brain, while the same agents do not essentially influence the translation processes in the liver and all other organs of the animal (human) organism. The main aim of the present monograph is to review and analyze the data obtained recently in the course of biochemical research of several neurotropic PSI (methyl mercury, lithium salts). However, this is not the single aim of the book. Thus, besides this the present monograph deals with analysis of the general peculiarities of action of some non-neurotrophic inhibitors which are able, nevertheless, to direct a number of specific neurotrophic effects (Cordycepin, tRNA).(ABSTRACT TRUNCATED AT 400 WORDS) 相似文献
58.
目的:了解艾芬地尔干预对氯化锂(LiCl)-匹罗卡品(Pilo)致(癎)大鼠脑电图随时间变化的特征.方法:通过腹腔注射LiCl-Pilo建立癫(癎)动物模型.60只雄性Wistar大鼠分为对照组、模型组和艾芬地尔干预组,分别在造模后第7、15、30、60天四个时间点观察各组大鼠行为、脑电图改变,每一个时间点5只大鼠.结果:对照组无NFDA1性发作,经过4-20天的潜伏期后,干预组及模型组的脑电图波幅及频率骤然减低,在慢性期干预组较模型组的波幅逐渐增高,频率逐渐增快,但仍未达发作当时的水平,且两组间比较差异无统计学意义.干预组较模型组更早更快趋于正常化.结论:艾芬地尔在LiCl-Pilo致(癎)大鼠模型中具有抗惊厥作用,慢性期脑电图有特征性改变. 相似文献
59.
生物工程技术制备人源抗-HBs Fab 片段 总被引:1,自引:2,他引:1
目的:用生物工程技术制备人源性抗-HBsFab。方法:将从抗体文库中筛选出的人源抗-HBsFab基因克隆入pBAD/gⅢA载体,进而转化Tpo10大肠杆菌,对重组质粒菌发酵表达后,利用Ni-NTA-Agarose螯合层析柱纯化周质腔可溶性Fab蛋白。对所得包涵体依次变性,溶解,纯化后,利用透析进行复性,用Western blot检测Fab蛋白的特异性,Dot blot测定其生物学活性。结果:经Ni-NTA-Agarose柱纯化的周质腔可溶性Fab蛋白,有较好的生物学活性,并且总量达到80mg/L。对所获包涵体进行透析复性后,也可得到少量有活性的蛋白,但比例很小。结论;用pBAD/gⅢA-Top10表达系统表达人源抗-HBsFab片段,发酵培养后,经有效纯化可得到生物学活性较好的可溶性蛋白。为人源抗-HBsFab片段的大量制备提供了有效手段。 相似文献
60.